Cell therapy for left ventricular remodeling

Current Heart Failure Reports

Volumn 4, Issue 1, 2007, Pages 3-10

  Taylor, Doris A ^a,b   Zenovich, Audrey G ^a  

^a Department of Medicine ^*

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ANGIOGENESIS; CARDIOMYOPATHY; CELL THERAPY; CELL TRANSPLANTATION; CLINICAL TRIAL; HEART FAILURE; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; MYOBLAST; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HUMANS; MYOBLASTS, SKELETAL; RESEARCH DESIGN; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 34247547295     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-007-0019-0     Document Type: Review

References (34)

1. Thom T, Haase N, Rosamond W, et al.: Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-151.
2. Udelson J, Patten R, Konstam M: New concepts in postinfarction ventricular remodeling. Rev Cardiovasc Med 2003, 4:S3-12.
3. Levy D, Kenchaiah S, Larson MG, et al.: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397-1402.
4. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al.: Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003, 108:457-463.
5. Schachinger V, Erbs S, Elsasser A, et al.: Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355:1210-1221.
6. Menasche P, Hagege AA, Vilquin JT, et al.: Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003, 41:1078-1083.
7. Silva G, Perin E, Dohmann H, et al.: Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex Heart Inst J 2004, 31:214-219.
8. Menasche P: Late-breaking clinical trials III. First randomized placebo-controlled myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial. Presented at the Scientific Sessions of the American Heart Association. Chicago, IL; November 15, 2006.
9. Abbate A, Bussani R, Amin MS, et al.: Acute myocardial infarction and heart failure: role of apoptosis. Int J Biochem Cell Biol 2006, 38:1834-1840.
10. Schachinger V, Assmus B, Britten MB, et al.: Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004, 44:1690-1699.
11. Schachinger V, Assmus B, Honold J, et al.: Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial. Clin Res Cardiol 2006, 95:13-22.
12. Lunde K, Solheim S, Aakhus S, et al.: Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355:1199-1209.
13. Kuethe F, Richartz BM, Sayer HG, et al.: Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 2004, 97:123-127.
14. Wollert KC, Meyer GP, Lotz J, et al.: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
15. Meyer G, Wollert K, Lotz J, et al.: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
16. Schaefer A, Meyer G, Fuchs M, et al.: Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 2006, 27:929-935.
17. • Rosenzweig A: Cardiac cell therapy - mixed results from mixed cells. New Eng J Med 2006, 355:1274-1277. Editorial accompanying three recent clinical trials of BMNCs in AMI patients.
18. Ince H, Petzsch M, Rehders T, et al.: Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J Endovasc Ther 2004, 11:695-704.
19. Dib N, Michler R, Pagani F, et al.: Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005, 112:1748-1755.
20. Chachques JC, Herreros J, Trainini J, et al.: Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004, 95(Suppl 1):S29-33.
21. Blatt A, Cotter G, Leitman M, et al.: Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy. Am Heart J 2005, 150:986.
22. Perin EC, Dohmann HF, Borojevic R, et al.: Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004, 110:II213-218.
23. Perin EC, Dohmann HF, Borojevic R, et al.: Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107:2294-2302.
24. Gavira J, Herreros J, Perez A, et al.: Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 2006, 131:799-804.
25. Herreros J, Prosper F, Perez A, et al.: Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 2003, 24:2012-2020.
26. Siminiak T, Kalawski R, Fiszer D, et al.: Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004, 148:531-537.
27. Smits PC, van Geuns RJ, Poldermans D, et al.: Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003, 42:2063-2069.
28. Siminiak T, Fiszer D, Jerzykowska O, et al.: Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 2005, 26:1188-1195.
29. Salukhe T, Dimopoulos K, Francis D: Cardiac resynchronization may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC. Int J Cardiol 2004, 93:101-103.
30. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
31. • Yancy C, Fonarow G: Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry. Curr Heart Fail Rep 2004, 1:121-128. Report from ADHERE, highlighting the role of a centralized registry in measuring outcomes of management of HF patients.
32. • Rosen MR: Are stem cells drugs? The regulation of stem cell research and development. Circulation 2006, 114:1992-2000. Perspective on regulation of cell therapy by the Food and Drug Administration.
33. • Simons M: Angiogenesis: where do we stand now? Circulation 2005, 111:1556-1566. Discussion of recent progress and lessons learned in angiogenesis trials.
34. Wilke N, Zenovich A, Jerosch-Herold M, Henry T: Cardiac magnetic resonance imaging for the assessment of myocardial angiogenesis. Curr Interv Cardiol Rep 2001, 3:205-212.